Moreover, TNBC patients with low PKM expression showed a trend towards benefitting from radiotherapy not quite reaching significance, while there is no difference in response to radiotherapy in TNBC patients with a high expression of PKM (Fig. 2 H).
← all excerpts
Precise metabolomics identifies glycolysis-related pyruvate kinase M activity as regulator of the S-phase-specific radiation response in triple-negative breast cancer cells.
1
—
—